Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 4 | 2016 | 741 | 1.120 |
Why?
|
| Autoantigens | 4 | 2016 | 132 | 0.970 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 142 | 0.930 |
Why?
|
| Glucose-6-Phosphate Isomerase | 3 | 2013 | 8 | 0.920 |
Why?
|
| Thymus Gland | 2 | 2015 | 197 | 0.860 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.540 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2016 | 38 | 0.530 |
Why?
|
| Antigen Presentation | 2 | 2015 | 215 | 0.510 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 172 | 0.480 |
Why?
|
| Models, Immunological | 1 | 2015 | 81 | 0.480 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 1229 | 0.410 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 407 | 0.390 |
Why?
|
| Immune Tolerance | 1 | 2013 | 344 | 0.370 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 756 | 0.210 |
Why?
|
| Mice | 6 | 2016 | 11949 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 1583 | 0.190 |
Why?
|
| Organoids | 1 | 2021 | 69 | 0.180 |
Why?
|
| Precision Medicine | 2 | 2021 | 414 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 243 | 0.150 |
Why?
|
| Genomics | 2 | 2021 | 784 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 1397 | 0.140 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.130 |
Why?
|
| Animals | 6 | 2016 | 27715 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 872 | 0.130 |
Why?
|
| Neoplasms | 2 | 2021 | 3030 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 29 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2015 | 296 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 453 | 0.110 |
Why?
|
| CD79 Antigens | 1 | 2013 | 17 | 0.110 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2013 | 21 | 0.110 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2013 | 42 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 56 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 263 | 0.100 |
Why?
|
| Bronchi | 1 | 2013 | 230 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 314 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 814 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2409 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 269 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1553 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2042 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 86 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 83 | 0.050 |
Why?
|
| Fluorescence | 1 | 2021 | 104 | 0.050 |
Why?
|
| Humans | 4 | 2021 | 90640 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2021 | 227 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 280 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 674 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1695 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1770 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1286 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1462 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 200 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 167 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 560 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 646 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1549 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 2329 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3030 | 0.020 |
Why?
|
| Male | 2 | 2021 | 42967 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 1219 | 0.020 |
Why?
|
| Female | 2 | 2021 | 46894 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1991 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 26347 | 0.010 |
Why?
|